BIB News and Press, ProShares Ultra Nasdaq Biotechnology

2026-03-08 14:42:00 ET Transcript Oscar Pulido: American consumers remain one of the most important signals for the US economy. For the last few years, they've repeatedly defied expectations, continuing to spend despite higher inflation and higher interest rates.... Re...

2026-03-06 04:00:00 ET By Christian Floro, CFA, CMT Market Strategist ... Read the full article on Seeking Alpha For further details see: The Trump Administration's Affordability Plan

2026-02-26 06:56:00 ET Optimism builds as positioning evolves Equity managers are navigating a challenging backdrop: concentrated market leadership, wide valuation gaps between U.S. and non-U.S. equities, and policy uncertainty as we move through Q1 2026. AI positioning remains ...

2026-01-28 23:50:00 ET After the run higher in valuations, investors may want to consider smaller, mid-cap stocks for both portfolio diversification and growth potential, according to Brian Dasuch, Portfolio Specialist with T. Rowe Price. ... Read the full article on Seeking A...

2026-01-22 13:04:02 ET More on Novartis Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Novartis: A Mispriced Hedge In A Crowded Equity Mark...

2026-01-22 06:07:00 ET By Vinay Thapar, CFA and Jane Bleeg More clarity on regulatory and policy issues can help healthcare stocks reassert their fundamental strengths. Read the full article on Seeking Alpha For further details see: Are Healthcare Stocks Pois...

2026-01-20 12:39:50 ET Fast facts and strategy of the Direxion Daily Healthcare Bull 3x Shares ETF The Direxion Daily Healthcare Bull 3X Shares ETF ( CURE ) is a leveraged ETF with a factor of 3x in the healthcare sector. CURE was launched on June 15, 2011 and has a net expense ...

2026-01-13 06:30:00 ET Transcript We just had three years of double-digit returns for S&P 500 that is quite rare, and if we make it into four depends a lot on earnings. Q4 is starting to report, and there are three themes on my mind.... Read the full article on...

2026-01-08 12:42:09 ET More on Arcus Biosciences Arcus Biosciences: Casdatifan Takes Center Stage After STAR-221 Arcus Biosciences, Inc. (RCUS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript Arcus Biosciences: Refusing To Let The TIGIT Story Die...

2026-01-08 05:30:00 ET After a prolonged slump, investors are giving the healthcare sector a second look as lower interest rates, potential M&A and even AI innovation help to improve the outlook. Jacky He, Vice President for Portfolio Research at TD Asset Management, joins MoneyTalk...